Tag: Injectable Oestrogen
Par and Perrigo Pharmaceuticals Urged to Address and Remedy the National Shortage of Injectable Oestrogen
Callen-Lorde Community Health Center is leading a national coalition – with partners from Fenway Health in Boston and Treatment Action Group in New York City – that has collected 570 signatures for a petition calling on pharmaceutical companies Par and Perrigo to address and remedy the national shortage of injectable oestrogen.
Shortage Of Injectable Oestrogen Presents Possible Public Health Risk
Callen-Lorde Community Health Center warns of potential public health risk for transgender women and transfeminine people due to a U.S nationwide shortage of some generic and brand name injectable oestrogen. Makers of the drugs have reported manufacturing delays in getting the medications to the market.